Biomarkers and the Future of Pediatric Gastroenterology

Lindsay M Moye¹, Jon Marc Rhoads² and Yuying Liu²

Received: October 11, 2017;   Published: October 13, 2017

DOI: 10.26717/BJSTR.2017.01.000440

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Biomarker discovery in the field of pediatric gastroenterology is necessary so that clinicians can use objective, non-invasive ways to screen for a disease in its preclinical stage, measure disease severity or monitor response to a particular treatment. The utilization of high-throughput analyses, such as with proteomics and metabolomics, allows researchers to quickly investigate numerous methodologies and generate large datasets, while only requiring small quantities of the biological specimen.

Keywords : Biomarker; Proteomics; Metabolomics; High Throughput

Abbreviations : CD: Crohn’s Disease; HC: Healthy Controls

Abstract| Introduction| Pediatric Gastroenterology| Conclusion| References|